The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: A double-blind, placebo-controlled trial

Psychopharmacology

Volumn 188, Issue 1, 2006, Pages 12-17

  Zhang, Xiang Yang ^a,c,d   Zhou, Dong Feng ^a   Cao, Lian Yuan ^b   Wu, Gui Ying ^b  

^a PEKING UNIVERSITY SIXTH HOSPITAL   (China)

^b BEIJING HUILONGGUAN HOSPITAL   (China)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Antioxidant; Free radical; Immunity; Oxidative stress; Schizophrenia

Indexed keywords

ALKALINE PHOSPHATASE; CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GINKGO BILOBA EXTRACT; HALOPERIDOL; INTERLEUKIN 2; SUPEROXIDE DISMUTASE;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; BRIEF PSYCHIATRIC RATING SCALE; CD4 CD8 RATIO; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME BLOOD LEVEL; FEMALE; HELPER CELL; HUMAN; IMMUNE FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; SUPPRESSOR CELL; SYMPTOM; T LYMPHOCYTE;

ADULT; ANTIGENS, CD3; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BRIEF PSYCHIATRIC RATING SCALE; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; CHRONIC DISEASE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DRUGS, CHINESE HERBAL; FEMALE; GINKGO BILOBA; HALOPERIDOL; HUMANS; INTERLEUKIN-2; MALE; MIDDLE AGED; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPEROXIDE DISMUTASE; T-LYMPHOCYTE SUBSETS; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747625841     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-006-0476-2     Document Type: Article

References (18)

1. Causo C, Candore G, Cigna D, Colucc AT, Modica MA (1993) Biological significance of soluble IL-2 receptor. Mediators Inflamm 2:3-21
2. Cosentino M, Fietta A, Caldiroli E, Marino F, Rispoli L, Comelli M, Lecchini S, Frigo G (1996) Assessment of lymphocyte subsets and neutrophil leukocyte function in chronic psychiatric patients on long-term drug therapy. Prog Neuropsychopharmacol Biol Psychiatry 20:1117-1129
3. DeFeudis FV (1991) In vivo studies with EGb761. In: DeFeudis FV (ed) Ginkgo biloba extract (EGb): pharmacological activities and clinical applications. Elsevier, Paris, pp 61-66
4. Hildeman DA, Mitchell T, Teague TK, Henson P, Day BJ, Kappler J, Marrack PC (1999) Reactive oxygen species regulate activation-induced T cell apoptosis. Immunity 10:735-744
5. Jacobs BP, Browner WS (2000) Ginkgo biloba: a living fossil. Am J Med 108:341-342
6. Lohr JB, Kuczenski R, Niculescu AB (2003) Oxidative mechanisms and tardive dyskinesia. CNS Drugs 17:47-62
7. Maclennan KM, Darlington CL, Smith PF (2002) The CNS effects of Ginkgo biloba extracts and ginkgolide B. Prog Neurobiol 67:235-257
8. Muller N, Hofschuster E, Ackenheil M, Eckstein R (1993) T cells and psychopathology in schizophrenia: relationship to the outcome of neuroleptic therapy. Acta Psychiatr Scand 87:66-71
9. Muller N, Riedel M, Ackenheil M, Schwarz MJ (1999) The role of immune function in schizophrenia: an overview. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):62-68
10. Muller N, Riedel M, Gruber R, Ackenheil M, Schwarz MJ (2000) The immune system and schizophrenia. An integrative view. Ann N Y Acad Sci 917:456-467
11. Puebla-Perez AM, Lozoya X, Villasenor-Garcia MM (2003) Effect of Ginkgo biloba extract, EGb 761, on the cellular immune response in a hypothalamic-pituitary-adrenal axis activation model in the rat. Int Immunopharmacol 3:75-80
12. Sperner-Unterweger B, Whitworth A, Kemmler G, Hilbe W, Thaler J, Weiss G, Fleischhacker WW (1999) T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients. Schizophr Res 38:61-70
13. Tian YM, Tian HJ, Zhang GY, Dai YR (2003) Effects of Ginkgo biloba extract (EGb 761) on hydroxyl radical-induced thymocyte apoptosis and on age-related thymic atrophy and peripheral immune dysfunctions in mice. Mech Ageing Dev 124:977-983
14. Villemain F, Chatenoud L, Galinowski A, Homo-Delarche F, Ginestet D, Loo H, Zarifian E, Bach JF (1989) Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. Am J Psychiatry 146:609-616
15. Yao JK, Reddy RD, van Kammen DP (2001) Oxidative damage and schizophrenia: an overview of the evidence and its therapeutic implications. CNS Drugs 15:287-310
16. Zhang XY, Zhou DF, Zhang PY, Wu GY, Su JM, Cao LY (2001a) A double-blind, placebo-controlled trial of extract of Ginkgo biloba added to haloperidol in treatment-resistant patients with schizophrenia. J Clin Psychiatry 62:878-883
17. Zhang XY, Zhou DF, Su JM, Zhang PY (2001b) The effect of extract of ginkgo biloba added to haloperidol on superoxide dismutase in inpatients with chronic schizophrenia. J Clin Psychopharmacol 21:85-88
18. Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY (2002) Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia. J Psychiatr Res 36:331-336